Saturday 17 October 2026
Export AEHR’s income statement to Excel — free account
Aehr Test Systems
AEHR Technology Semiconductor Equipment & Materials
Aehr Test Systems' revenue for fiscal 2026 (year ended May 2026) was $50.0 million, down 15.2% from fiscal 2025. In the quarter to May 2026, revenue grew 33.7%, EPS grew 140.0% and free cash flow grew 133.2%, each against the same quarter a year earlier.
60.60
8.61
−12.44%
Follow AEHR
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
57.42 | 29.86 | 12.77 | 13.10 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
1,567.27 | (366.36) | (580.60) | (2,640.01) | |
P/B ratio |
13.08 | 9.74 | 5.20 | 6.08 | |
Price to Tangible BV |
14.41 | 11.43 | 6.19 | 7.35 | |
EV/Sales |
55.13 | 29.09 | 12.22 | 12.74 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(832.85) | (176.85) | (121.44) | (71.92) | |
EV/FCF |
(512.79) | (107.96) | (55.67) | (44.54) | |
Quick Ratio |
7.50 | 5.57 | 4.95 | 3.00 | |
Current Ratio |
10.33 | 10.97 | 10.62 | 7.06 | |
Net Debt/EBITDA |
353.67 | 10.96 | 8.16 | 7.22 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.25 | 0.30 | 0.37 | 0.39 | |
Operating CF/Net income |
1.32 | 1.15 | 0.36 | 0.14 | |
Capex/Depreciation |
(0.15) | (0.09) | (0.54) | (1.51) | |
Research and Development Expense of Revenue |
19.35% | 30.71% | 30.07% | 25.97% | |
Selling, General and Administrative Expense of Revenue |
29.63% | 42.96% | 44.86% | 43.00% | |
Intangible Assets out of Total Assets |
0.08 | 0.13 | 0.14 | 0.15 | |
Share Based Compensation of Revenue |
9.90% | 13.42% | 18.63% | 15.23% | |
Graham Net Nets |
0.05 | 0.06 | 0.10 | 0.08 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.26%) | (0.86%) | (1.33%) | (0.88%) | |
Free Cash Flow Yield |
(0.19%) | (0.90%) | (1.72%) | (2.18%) | |
Revenue per Share |
0.61 | 0.34 | 0.33 | 0.37 | |
Operating CF per Share |
0.06 | (0.12) | (0.04) | (0.01) | |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.05) | |
Free Cash Flow per Share |
0.06 | (0.12) | (0.05) | (0.06) | |
Cash per Share |
3.79 | 1.20 | 1.02 | 0.76 | |
Shareholders Equity per Share |
7.16 | 4.52 | 4.33 | 4.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.16 | 4.52 | 4.33 | 4.09 | |
Free Cash Flow |
1.70 | (3.76) | (1.64) | (1.67) | |
Working Capital |
166.59 | 87.16 | 79.88 | 72.14 | |
Capital Expenditures |
(0.13) | (0.07) | (0.47) | (1.39) | |
Net Current Asset Value |
157.27 | 77.65 | 70.23 | 62.35 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.05 | 0.13 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
15.83 | 11.90 | 8.81 | 10.81 | |
Average Payables |
6.74 | 4.53 | 4.20 | 4.48 | |
Average Inventory |
41.68 | 41.75 | 43.25 | 42.41 | |
Average Assets |
197.60 | 151.33 | 145.51 | 144.98 | |
Average Common Equity |
171.19 | 131.50 | 126.98 | 122.44 |
Columns are period end dates